Doximity Corp (DOCS) - Narx-foyda multiplikatori

Doximity Corp (DOCS) korporativ emblemasi va logotipi

Yuqori yalpi foyda marjasi va operatsion leveraj Doximity, Inc. (DOCS) kompaniyasiga a’lo darajadagi o’sish potentsialini taqdim etadi, buni kompaniyaning P/E diapazoni isbotlaydi, bunda ushbu ko’rsatkich 29.90 miqdorida qat’iy belgilangan. Biznes bulutli xizmatlar orqali tibbiy hujjatlashtirishni avtomatlashtirishga tayanadi. Biroq, qat’iy HIPAA qoidalari va farmatsevtika sektori marketing xarajatlariga bog’liqlik uning barqarorligini cheklaydi.

DOCS Doximity Inc: Narx-foyda koeffitsiyenti 04.07.2022 - 10.11.2026 oraligʻida

Doximity, Inc. kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahlili:Doximity, Inc.
Doximity, Inc. ishlab chiqargan mahsulot

P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini o'lchaydi va investorlarning kelajakdagi o'sish sur'atlariga bo'lgan kutganlarini aks ettiradi. Ushbu koeffitsiyent joriy bozor kapitalizatsiyasining yillik daromadga bo'linishi orqali hisoblanadi va aktiv uchun to'langan premiumning miqdorini belgilaydi. GURU.Markets platformasidagi Doximity, Inc. (DOCS) kompaniyasining oylik P/E dinamikasi, uning kengaytiriladigan bulutli tarmog'i va tibbiy hujjatlarni avtomatlashtirishdagi yuqori samaradorligi kontekstida Doximity, Inc. baholanishining adolatli ekanligini baholashga yordam beradi.

Raqobatdosh kompaniyalar

Narx-foyda multiplikatori VEEV (veeva.com)|P/E multiplikatori HQY|Waystar Health - Narx-foyda multiplikatori|Narxning foydaga nisbati CorVel Healthcare CRVL|Privia Medical Group (PRVA) - Kapitalizatsiyaning foydaga nisbati|HURN: Narx-foyda koeffitsiyenti|CERT (certara.com) - Narx-foyda multiplikatori|OMCL: P/E multiplikatori|GDRX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Schrödinger Inc.|Narx-foyda koeffitsiyenti Phreesia Health (PHR)|P/E multiplikatori OMDA|Biznesning o‘zini qoplash muddati evolenthealth.com|HealthStream - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati DH (Definitive Healthcare Corp)|CCSI: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Agilon Health Corp|ABSI (Absci) - Narx-foyda koeffitsiyenti|soyoung.com - Kompaniya qiymatining sof foydaga nisbati|NRC (National Research Corporation) - P/E multiplikatori|Spok Holdings Inc (SPOK) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati OptimizeRx Corp. (OPRX)|TruBridge Corp - Narx-foyda multiplikatori|P/E multiplikatori SLP (Simulations Plus, Inc.)|SOPH - Narx-foyda koeffitsiyenti|HCAT: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati CareCloud, Inc. CCLD|RSSS: P/E multiplikatori|Narx-foyda multiplikatori DLHC|Narxning foydaga nisbati OneMedNet Corp|Kapitalizatsiyaning foydaga nisbati scienture.com SCNX|P/E multiplikatori HCTI|Narx-foyda koeffitsiyenti ispecimen.com ISPC|Narxning foydaga nisbati Bullfrog AI BFRG|Biznesning o‘zini qoplash muddati SCWorx Inc (WORX)|MSP Recovery Inc - P/E multiplikatori|Biznesning o‘zini qoplash muddati iCoreConnect Inc. ICCT|MEDS (TRxADE HEALTH) - Narx-foyda koeffitsiyenti|ORGS: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti RCM|SHCR: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Streamline Health Solutions (STRM)|Narx-foyda koeffitsiyenti syrahealth.com SYRA|P/E multiplikatori AMEH (Apollo Medical Holdings, Inc.)|Model N Inc (MODN) - Kapitalizatsiyaning foydaga nisbati|NextGen - P/E multiplikatori